Comparing Oral vs. Injectable Semaglutide: Is One More Effective Than the Other?
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
WebMD13d
New FDA Warning Added to Popular Weight Loss Drugs
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...
Has semaglutide transformed treatment of diabetes and obesity in India?
So what is semaglutide and who uses it in India? Semaglutide belongs to the class of drugs called Glucagon-like peptide-1 ...
NJBIZ1d
Pharma giants defend against high-stakes lawsuit over weight loss drugs
Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...
WebMD7d
New Guidance for Patients Taking GLP-1 Drugs Before Surgery
As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...
Onlymyhealth11d
FDA Issues New Warning For Popular Weight Loss Drugs—Here's What You Need To Know
The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to stay safe before surgeries ...
Nearly one in four Brits would take weight-loss jabs for free on NHS
Glucagon-like peptide-1 (GLP-1) agonist are a family of medications that help manage blood sugar in patients with type 2 ...
Weight Loss Injections: What You Need to Know, From Costs to Alternatives
Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...
Lexaria Bioscience provides GLP-1 industry update
Lexaria Bioscience (LEXX) provides the following glucagon-like peptide-1 industry update. It is no surprise that Novo Nordisk’s ...
FDA adds new warning to weight loss drugs
The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...